DGS Capital Management »

Puma Biotechnology shares owned by DGS Capital Management

Quarter-by-quarter ownership of Puma Biotechnology (PBYI) shares owned by DGS Capital Management from 13F filings

Historical chart of DGS Capital Management investment in Puma Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Puma Biotechnology held by DGS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Puma Biotechnology by DGS Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $67k 10k 6.39

More positions owned by DGS Capital Management

Ishares Short-term National Muni Bond Etf Etf (SUB)
Coinbase Global Inc Com Cl A Stock (COIN)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Palantir Technologies Inc Cl A Stock (PLTR)
Celestica Stock (CLS)
Taiwan Semiconductor Manufact Adr (TSM)
State Street Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Meta Platforms Inc Cl A Stock (META)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Global Equity Factor Etf Etf (GLOF)
Amazon Stock (AMZN)
Ishares Short Maturity Municipal Bond Active Etf Etf (MEAR)

View all positions for DGS Capital Management

Top funds holding Puma Biotechnology

Acorn Capital Advisors
Vanguard Group
BlackRock
Renaissance Technologies
Acadian Asset Management
Vanguard Capital Management
Vanguard Portfolio Management
American Century Companies
Millennium Management
Dimensional Fund Advisors
LSV Asset Management
O'shaughnessy Asset Management
Geode Capital Management
Kennedy Capital Management
State Street Corporation

View all funds holding Puma Biotechnology